Adenosine Safety and Benefit in Emergency Heart Attack Treatment
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether giving a medication called adenosine before emergency heart catheterization (a tube procedure to open blocked arteries) helps patients having a heart attack. Adenosine may protect heart tissue and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be having an acute STEMI (a specific type of heart attack where a major artery is completely blocked)
- You must be undergoing primary PCI (emergency catheterization to reopen your blocked artery)
- You must be 18 years or older
- You cannot be in cardiogenic shock (severe heart failure) when you arrive at the hospital
- You cannot have a heart block (an electrical problem preventing your heart's chambers from beating together)
- You must not be allergic to adenosine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving adrenaline (a medicine that helps blood vessels relax) directly into the heart artery during a procedure to open a blocked artery can prevent a complication called 'no reflow' (where blood still doesn't flow well after the blockage is cleared). It is for people having a specific type of heart attack (STEMI) and being treated within 12 hours.
This trial tests whether giving a medication before angioplasty reduces damage to the heart muscle in people having a severe heart attack. It may help improve blood flow and recovery.
This trial tests whether patients who have had a heart attack with a specific type of artery blockage can be safely treated without placing a metal stent (tube) in their artery. Doctors will monitor whether the blockage stays open on its own.
This trial tests if ivabradine, a drug that lowers heart rate, can help patients in cardiogenic shock after a type of heart attack called STEMI. It is for patients with a fast heart rate (at least 100 beats per minute) who cannot take beta-blockers.
This study tests whether adding a medication called adenosine to the heart-protection solution used during heart surgery helps protect the heart better. If you are having a planned valve replacement or coronary bypass, this could potentially improve your recovery.
This study tests different ways of restoring blood flow for people having a heart attack (STEMI) when the usual emergency procedure (primary PCI) may be delayed. It aims to see if giving a clot-busting medicine beforehand is as good as waiting for the procedure, or if another approach works better.
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.